Fracture clinical trials

Explore recruiting fracture clinical trials.

Recruiting fracture studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fracture trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or denosumab to Stereotaxic radiotherapy in the treatment of vertebral metastases (ZOSTER)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe Osteogenesis Imperfecta compared with a combination of historical and untreated prospective controls.

Netherlands, Sweden

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Preventive effect of 5% lidocaine patch on the development of neuropathic pain following an osteoporotic vertebral fracture: A proof-of-concept, controlled, randomized trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

“Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Oral laxatives after hip fracture surgery: A randomised controlled trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Hemodynamic safety of isobaric levobupivacaine versus isobaric bupivacaine for subarachnoid anesthesia in patients over 65 years old undergoing hip fracture surgery

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Fracture trials by city

Fracture in Toronto Fracture in Vancouver Fracture in Montreal Fracture in Calgary Fracture in Edmonton Fracture in Ottawa Fracture in Winnipeg Fracture in Quebec City Fracture in Hamilton Fracture in Kitchener Fracture in London Fracture in Halifax Fracture in New York Fracture in Los Angeles Fracture in Chicago Fracture in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease